OAKTREE CAPITAL MANAGEMENT LP - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 40 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
OAKTREE CAPITAL MANAGEMENT LP ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2020$13,444,000
+261.6%
13,428,000
+283.7%
0.29%
+178.1%
Q1 2020$3,718,000
-74.6%
3,500,000
-73.3%
0.10%
-21.1%
Q4 2018$14,628,000
-11.5%
13,120,000
-4.4%
0.13%
-40.1%
Q3 2018$16,527,000
+177.9%
13,720,000
+174.4%
0.22%
+167.5%
Q2 2018$5,947,000
-80.7%
5,000,000
-80.7%
0.08%
-82.8%
Q4 2017$30,822,000
+153.8%
25,915,000
+159.2%
0.48%
+166.9%
Q3 2017$12,142,000
+103.5%
10,000,000
+100.0%
0.18%
+84.7%
Q2 2017$5,968,000
-83.1%
5,000,000
-78.4%
0.10%
-73.7%
Q1 2015$35,265,000
-59.8%
23,188,000
-67.7%
0.37%
-60.3%
Q4 2014$87,691,000
+18.8%
71,763,000
+7.4%
0.94%
-23.4%
Q3 2014$73,802,000
+4.8%
66,800,0000.0%1.22%
-0.3%
Q2 2014$70,446,000
+0.1%
66,800,000
+6.0%
1.23%
-7.6%
Q1 2014$70,357,000
+73.6%
63,045,000
+68.1%
1.33%
+78.3%
Q4 2013$40,523,00037,500,0000.74%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q2 2017
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 4,885,000$5,468,0000.79%
ADVENT CAPITAL MANAGEMENT /DE/ 23,153,000$25,858,0000.62%
RWC Asset Management LLP 7,300,000$8,119,0000.42%
IRON Financial LLC 460,000$513,0000.40%
Calamos Advisors LLC 47,578,000$53,058,0000.35%
EDMOND DE ROTHSCHILD HOLDING S.A. 7,175,000$7,979,0000.28%
Calamos Wealth Management LLC 1,370,000$1,528,0000.23%
SSI INVESTMENT MANAGEMENT LLC 1,835,000$2,043,0000.19%
OAKTREE CAPITAL MANAGEMENT LP 13,120,000$14,628,0000.13%
PALISADE CAPITAL MANAGEMENT, LP 3,221,000$3,613,0000.13%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders